Literature DB >> 17947366

Subarachnoid hemosiderosis and superficial cortical hemosiderosis in cerebral amyloid angiopathy.

J Linn1, J Herms, M Dichgans, H Brückmann, G Fesl, T Freilinger, M Wiesmann.   

Abstract

Cerebral amyloid angiopathy (CAA) is an important cause of intracerebral hemorrhage. Its definite diagnosis still requires histopathologic demonstration of vascular amyloid. Thus, further improvement of noninvasive imaging methods would be desirable. Here we present 3 patients with histologically proved CAA, in which superficial cortical hemosiderosis and subarachnoid hemosiderosis were present in T2*-weighted MR images. Thus, we propose that these 2 findings might be valuable as noninvasive diagnostic markers for CAA.

Entities:  

Mesh:

Year:  2007        PMID: 17947366      PMCID: PMC8119072          DOI: 10.3174/ajnr.A0783

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  14 in total

1.  Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.

Authors:  K A Knudsen; J Rosand; D Karluk; S M Greenberg
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

Review 2.  Spontaneous intracerebral hemorrhage.

Authors:  A I Qureshi; S Tuhrim; J P Broderick; H H Batjer; H Hondo; D F Hanley
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

3.  Superficial siderosis.

Authors:  N Kumar; A A Cohen-Gadol; R A Wright; G M Miller; D G Piepgras; J E Ahlskog
Journal:  Neurology       Date:  2006-04-25       Impact factor: 9.910

Review 4.  Cerebral amyloid angiopathy. A critical review.

Authors:  H V Vinters
Journal:  Stroke       Date:  1987 Mar-Apr       Impact factor: 7.914

5.  Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly)

Authors:  F Garzuly; R Vidal; T Wisniewski; F Brittig; H Budka
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

6.  Petechial hemorrhages accompanying lobar hemorrhage: detection by gradient-echo MRI.

Authors:  S M Greenberg; S P Finklestein; P W Schaefer
Journal:  Neurology       Date:  1996-06       Impact factor: 9.910

7.  Familial leptomeningeal amyloidosis with a transthyretin variant Asp18Gly representing repeated subarachnoid haemorrhages with superficial siderosis.

Authors:  K Jin; S Sato; T Takahashi; H Nakazaki; Y Date; M Nakazato; T Tominaga; Y Itoyama; S Ikeda
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-10       Impact factor: 10.154

8.  Cerebral amyloid angiopathy as a cause of subarachnoid hemorrhage.

Authors:  T Ohshima; T Endo; H Nukui; S Ikeda; D Allsop; T Onaya
Journal:  Stroke       Date:  1990-03       Impact factor: 7.914

Review 9.  Superficial siderosis of the central nervous system.

Authors:  J M Fearnley; J M Stevens; P Rudge
Journal:  Brain       Date:  1995-08       Impact factor: 13.501

10.  Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy.

Authors:  S M Greenberg; G W Rebeck; J P Vonsattel; T Gomez-Isla; B T Hyman
Journal:  Ann Neurol       Date:  1995-08       Impact factor: 10.422

View more
  50 in total

Review 1.  Multimodality Review of Amyloid-related Diseases of the Central Nervous System.

Authors:  Michelle M Miller-Thomas; Adam L Sipe; Tammie L S Benzinger; Jonathan McConathy; Sarah Connolly; Katherine E Schwetye
Journal:  Radiographics       Date:  2016 Jul-Aug       Impact factor: 5.333

2.  Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.

Authors:  Hyemin Jang; Young Kyoung Jang; Hee Jin Kim; David John Werring; Jin San Lee; Yeong Sim Choe; Seongbeom Park; Juyeon Lee; Ko Woon Kim; Yeshin Kim; Soo Hyun Cho; Si Eun Kim; Seung Joo Kim; Andreas Charidimou; Duk L Na; Sang Won Seo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-04-02       Impact factor: 9.236

3.  Recurrence of Lobar Hemorrhage: A Red Flag for Cerebral Amyloid Angiopathy-related Inflammation?

Authors:  Vaibhav Rastogi; Lauren L Donnangelo; Ganesh Asaithambi; Sharatchandra Bidari; Anna Y Khanna; Vishnumurthy Shushrutha Hedna
Journal:  Innov Clin Neurosci       Date:  2015 May-Jun

4.  Cortical vein thrombosis: the diagnostic value of different imaging modalities.

Authors:  Jennifer Linn; Stefan Michl; Bochmann Katja; Thomas Pfefferkorn; Martin Wiesmann; Sabine Hartz; Martin Dichgans; Hartmut Brückmann
Journal:  Neuroradiology       Date:  2010-01-28       Impact factor: 2.804

5.  Superficial siderosis in cerebral amyloid angiopathy.

Authors:  J Linn; H Brückmann
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-22       Impact factor: 3.825

6.  Convexity subarachnoid hemorrhage in cerebral amyloid angiopathy: the saga continues.

Authors:  Andreas Charidimou
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-18       Impact factor: 6.200

7.  Frequency and appearance of hemosiderin depositions after aneurysmal subarachnoid hemorrhage treated by endovascular therapy.

Authors:  Bernhard Falter; Martin Wiesmann; Jessica Freiherr; Omid Nikoubashman; Michael Mull
Journal:  Neuroradiology       Date:  2015-07-19       Impact factor: 2.804

8.  Cerebral amyloid angiopathy revealed by rapidly progressing leptomeningeal lesions.

Authors:  Armelle Chouraki; Adeline Rollin-Sillaire; Vincent Deramecourt; Fahed Zairi; Emilie Le Rhun; Charlotte Cordonnier; Christine Delmaire; Claude-Alain Maurage; Florence Pasquier
Journal:  J Neurol       Date:  2014-05-25       Impact factor: 4.849

9.  Sporadic cerebral amyloid angiopathy as a cause of relapsing lobar hemorrhage, convexal subarachnoid hemorrhage and cortical superficial siderosis.

Authors:  Renata Conforti; Angela Sardaro; Sossio Cirillo; Ciro Parlato
Journal:  Neurol Sci       Date:  2016-06-03       Impact factor: 3.307

Review 10.  Spontaneous Intracranial Hypotension: Atypical Radiologic Appearances, Imaging Mimickers, and Clinical Look-Alikes.

Authors:  K M Bond; J C Benson; J K Cutsforth-Gregory; D K Kim; F E Diehn; C M Carr
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-09       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.